Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 407

1.

Relationships between Clinical Presentation, Serology, Histology, and Duodenal Deposits of Tissue Transglutaminase Antibodies in Pediatric Celiac Disease.

Loberman-Nachum N, Schvimer M, Avivi C, Barshack I, Lahad A, Fradkin A, Bujanover Y, Weiss B.

Dig Dis. 2018;36(5):369-376. doi: 10.1159/000490377. Epub 2018 Jul 17.

PMID:
30016777
2.

Alternative RNA splicing of leucocyte tissue transglutaminase in coeliac disease.

Arbildi P, Sóñora C, Del Río N, Marqués JM, Hernández A.

Scand J Immunol. 2018 May;87(5):e12659. doi: 10.1111/sji.12659. Epub 2018 Apr 16.

PMID:
29543397
3.

Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.

Kang S, Oh SC, Min BW, Lee DH.

Anticancer Res. 2018 Feb;38(2):787-794.

PMID:
29374703
4.

A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants.

Minotti L, Baldassari F, Galasso M, Volinia S, Bergamini CM, Bianchi N.

Amino Acids. 2018 Apr;50(3-4):421-438. doi: 10.1007/s00726-017-2528-9. Epub 2018 Jan 8.

PMID:
29313085
5.

Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease.

Maglio M, Ziberna F, Aitoro R, Discepolo V, Lania G, Bassi V, Miele E, Not T, Troncone R, Auricchio R.

Nutrients. 2017 Sep 21;9(10). pii: E1050. doi: 10.3390/nu9101050.

6.

Associations of tissue transglutaminase antibody seropositivity with coronary heart disease: Findings from a prospective cohort study.

Heikkilä K, Rissanen H, Heliövaara M, Knekt P, Mäki M, Kaukinen K.

Nutr Metab Cardiovasc Dis. 2017 Sep;27(9):817-821. doi: 10.1016/j.numecd.2017.06.005. Epub 2017 Jun 15.

PMID:
28756971
7.

Prognostic value of Transglutaminase 2 in non-small cell lung cancer patients.

Chihong Z, Yutian L, Danying W, Ruibin J, Huaying S, Linhui G, Jianguo F.

Oncotarget. 2017 Jul 11;8(28):45577-45584. doi: 10.18632/oncotarget.17374.

8.

Elevated Serum Tissue Transglutaminase Antibodies in Children With Eosinophilic Esophagitis.

Le Fevre AK, Walker MM, Hadjiashrafy A, Bhatia R, Mattes J, Talley NJ, Nightingale S.

J Pediatr Gastroenterol Nutr. 2017 Jul;65(1):69-74. doi: 10.1097/MPG.0000000000001437.

PMID:
28644352
9.

Transglutaminase 2 is upregulated in primary hepatocellular carcinoma with early recurrence as determined by proteomic profiles.

Yamaguchi H, Kuroda K, Sugitani M, Takayama T, Hasegawa K, Esumi M.

Int J Oncol. 2017 May;50(5):1749-1759. doi: 10.3892/ijo.2017.3917. Epub 2017 Mar 20.

PMID:
28339069
10.

Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2.

Thangaraju K, Király R, Demény MA, András Mótyán J, Fuxreiter M, Fésüs L.

PLoS One. 2017 Mar 1;12(3):e0172189. doi: 10.1371/journal.pone.0172189. eCollection 2017.

11.
12.

Elevated transglutaminase-2 expression in the epidermis of psoriatic skin and its role in the skin lesion development.

Su CC, Su TR, Lai JC, Tsay GJ, Lin HK.

J Dermatol. 2017 Jun;44(6):699-702. doi: 10.1111/1346-8138.13742. Epub 2017 Feb 2.

PMID:
28150335
13.

Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet.

Leonard MM, Weir DC, DeGroote M, Mitchell PD, Singh P, Silvester JA, Leichtner AM, Fasano A.

J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):286-291. doi: 10.1097/MPG.0000000000001460.

14.

Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.

Kerr C, Szmacinski H, Fisher ML, Nance B, Lakowicz JR, Akbar A, Keillor JW, Lok Wong T, Godoy-Ruiz R, Toth EA, Weber DJ, Eckert RL.

Oncogene. 2017 May 25;36(21):2981-2990. doi: 10.1038/onc.2016.452. Epub 2016 Dec 12.

15.

Antitissue Transglutaminase Normalization Postdiagnosis in Children With Celiac Disease.

Isaac DM, Rajani S, Yaskina M, Huynh HQ, Turner JM.

J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):195-199. doi: 10.1097/MPG.0000000000001480.

PMID:
27906802
16.

Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.

Monteagudo A, Ji C, Akbar A, Keillor JW, Johnson GVW.

Biochem Biophys Res Commun. 2017 Jan 22;482(4):942-947. doi: 10.1016/j.bbrc.2016.11.137. Epub 2016 Nov 27.

17.

Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer.

Lee J, Yakubov B, Ivan C, Jones DR, Caperell-Grant A, Fishel M, Cardenas H, Matei D.

Neoplasia. 2016 Nov;18(11):689-698. doi: 10.1016/j.neo.2016.09.003. Epub 2016 Oct 25.

18.

Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.

Hnida K, Stamnaes J, du Pré MF, Mysling S, Jørgensen TJ, Sollid LM, Iversen R.

J Biol Chem. 2016 Dec 2;291(49):25542-25552. Epub 2016 Oct 26.

19.

Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.

Carbone C, Di Gennaro E, Piro G, Milone MR, Pucci B, Caraglia M, Budillon A.

Amino Acids. 2017 Mar;49(3):517-528. doi: 10.1007/s00726-016-2338-5. Epub 2016 Oct 19.

PMID:
27761756
20.

Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?

Chrobok NL, Sestito C, Wilhelmus MM, Drukarch B, van Dam AM.

Amino Acids. 2017 Mar;49(3):441-452. doi: 10.1007/s00726-016-2334-9. Epub 2016 Sep 22. Review.

Supplemental Content

Support Center